The 2 Minute Medicine® Podcast – Shingles Vaccine Linked to Lower Dementia Risk, Whole-Body MRI Screening, Andes Hantavirus, GLP-1 Emotional Blunting, and “Cortisol Face”

The 2 Minute Medicine® Podcast – Shingles Vaccine Linked to Lower Dementia Risk, Whole-Body MRI Screening, Andes Hantavirus, GLP-1 Emotional Blunting, and “Cortisol Face”

In this episode, we explore how artificial intelligence is continuing to move deeper into healthcare infrastructure and clinical practice. We begin with the Food and Drug Administration's review of an artificial intelligence tool designed to predict drug-induced liver injury during drug development. We then examine a new certification program launched by The Joint Commission focused on responsible artificial intelligence governance in healthcare organizations. Finally, we discuss how pediatric hospitals are beginning to deploy generative artificial intelligence tools to reduce administrative burden and support clinical workflows.

The 2 Minute Medicine® Podcast - Shingles Vaccine & Dementia Risk, Whole-Body MRI Scans, Andes Hantavirus, GLP-1 Emotional Blunting, and "Cortisol Face"

In this episode, we explore how social media, celebrity influence, and emerging science continue to shape healthcare conversations around the world. The article of the week comes from from Annals of Internal Medicine entitled “Dementia Risk After Recombinant Herpes Zoster Vaccination in Older Adults With a Recent Skilled-Nursing Facility Stay: A Target Trial Emulation.” In the second half, we take a deep dive into the growing whole-body MRI screening trend promoted by celebrities and the concerns radiologists are raising about incidental findings and unnecessary follow-up testing. We then examine a rare Andes hantavirus outbreak aboard an expedition cruise ship that prompted contact tracing efforts across 32 countries. Next, we discuss reports of emotional blunting among some patients taking GLP-1 receptor agonists alongside new genetic data that may explain why certain individuals do not respond to these medications. Finally, we break down the viral “cortisol face” trend and why endocrinologists are cautioning against unnecessary cortisol testing.

The 2 Minute Medicine® Podcast- Asundexian for Secondary Stroke Prevention, “Fibermaxxing,” Red Light Therapy, Mouth Taping Risks, and WHO Schizophrenia Care Initiative Summary

In this episode, we explore how social media and celebrity influence are reshaping health behaviors at scale. The article of the week comes from the New England Journal of Medicine and is entitled “Asundexian for secondary stroke prevention.”We start with the viral “Fibermaxxing” trend and its growing focus on microbiome health and satiety. We then examine how Jennifer Aniston’s longevity campaign has pushed red light therapy into the mainstream wellness conversation. Next, we break down an urgent safety warning from the American Lung Association regarding the risks of the mouth taping sleep trend. We conclude with a major global initiative from the World Health Organization aimed at closing the longstanding mortality gap in schizophrenia through integrated care models.

The 2 Minute Medicine® Podcast- Talzenna in Prostate Cancer, Safer Anticoagulation Strategies, Retatrutide’s Metabolic Impact, and FDA Oversight of GLP-1 Therapies Summary:

In this episode of the 2 Minute Medicine® Podcast, we explore major advances in precision medicine, beginning with the Phase 3 TALAPRO-3 trial demonstrating improved outcomes with talazoparib combined with enzalutamide in metastatic prostate cancer. We review new evidence from the COBRRA trial comparing apixaban and rivaroxaban, highlighting a significantly improved bleeding profile without loss of efficacy. The episode then examines Eli Lilly’s investigational triple-agonist retatrutide, which is showing unprecedented weight loss and glycemic control in patients with type 2 diabetes. Finally, we discuss a recent FDA warning issued to Novo Nordisk regarding delayed adverse event reporting and what this means for clinicians as GLP-1 therapies continue to expand rapidly in clinical practice.

The 2 Minute Medicine® Podcast- Roche’s AI Factory, Amazon’s Health Assistant, Surgical Robotics Breakthroughs, and Chatbot Safety Concerns

In this special deep-dive episode of the 2 Minute Medicine® Podcast, we explore the rapid transformation of artificial intelligence across the healthcare landscape, beginning with Roche’s launch of a large-scale AI factory designed to accelerate drug discovery and manufacturing. We review how NVIDIA-powered systems and “Lab-in-the-Loop” models are enabling real-time refinement of biological predictions and reshaping pharmaceutical research pipelines. The episode then examines Amazon’s expansion of its Health AI assistant, highlighting how conversational AI is changing patient engagement and clinical workflows. We also discuss emerging advances in surgical robotics, including NVIDIA’s Isaac GR00T N model, which may enhance procedural precision and standardize outcomes. Finally, we address growing ethical concerns surrounding AI-powered mental health chatbots, including risks related to bias, safety, and inadequate escalation in high-risk scenarios.